Embryonic Tissues Center EmCell, Ltd. – Trademark Portfolio
Entity Type: 03
Embryonic Tissues Center EmCell, Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 6 Nice Classification classes. The owner is based in Kiev 03110.
Solomenskaya Street 17, POB 80
Kiev 03110 , UA
Showing of trademarks Trademarks
Trademark Classifications
Embryonic Tissues Center EmCell, Ltd.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Embryonic Tissues Center EmCell, Ltd. have?
Embryonic Tissues Center EmCell, Ltd. has 1 U.S. trademark filed with the USPTO.
What trademark classes does Embryonic Tissues Center EmCell, Ltd. file in?
Embryonic Tissues Center EmCell, Ltd. files trademarks across 6 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What is Embryonic Tissues Center EmCell, Ltd.'s trademark registration success rate?
Embryonic Tissues Center EmCell, Ltd. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.